Medeiros, L. Jeffrey

Pathologic features of prognostic significance in adrenocortical carcinoma

Weiss, L. M., Medeiros, L. J., & Vickery, A. L. (1989) · The American Journal of Surgical Pathology

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 818

8p11 myeloproliferative syndrome: a review

Jackson, C. C., Medeiros, L. J., & Miranda, R. N. (2010) · Human Pathology

Eosinophilic Disorders and SyndromesAcute Myeloid Leukemia Research

Cited by 247

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Wang, W., Cortes, J. E., Tang, G., Khoury, J. D., Wang, S., Bueso-Ramos, C. E., DiGiuseppe, J. A., Chen, Z., Kantarjian, H. M., Medeiros, L. J., et al. (2016) · Blood

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 198

TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia

Tashakori, M., Kadia, T., Loghavi, S., Daver, N., Kanagal-Shamanna, R., Pierce, S., Sui, D., Wei, P., Khodakarami, F., Tang, Z., et al. (2022) · Blood

Acute Myeloid Leukemia ResearchCancer Genomics and Diagnostics

Cited by 111

NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms

Yu, L., Li, L., Medeiros, L. J., & Young, K. H. (2017) · Blood Reviews

NF-κB Signaling PathwaysLymphoma Diagnosis and Treatment

Cited by 105

Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor–resistant chronic lymphocytic leukemia with disease progression and Richter transformation

Kanagal‐Shamanna, R., Jain, P., Patel, K. P., Routbort, M., Bueso‐Ramos, C., Alhalouli, T., Khoury, J. D., Luthra, R., Ferrajoli, A., Keating, M., et al. (2019) · Cancer

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 98

Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia

Gong, Z., Medeiros, L. J., Cortes, J. E., Zheng, L., Khoury, J. D., Wang, W., Tang, G., Loghavi, S., Luthra, R., Yang, W., et al. (2017) · Blood Cancer Journal

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 56

Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis

Li, N., Lin, P., Zuo, Z., You, M. J., Shuai, W., Orlowski, R., Manasanch, E. E., Li, S., Xu, J., Garces, S., et al. (2023) · Cancer Medicine

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 19